» Articles » PMID: 18981650

Small LDL-cholesterol is Superior to LDL-cholesterol for Determining Severe Coronary Atherosclerosis

Overview
Date 2008 Nov 5
PMID 18981650
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Recent evidence suggests that small dense low-density lipoprotein (sd-LDL) particles are more atherogenic than large-LDL in spite of their lower cholesterol content. This study aimed to determine whether sd-LDL-cholesterol (sd-LDL-C) is superior to LDL-C as a biomarker of coronary heart disease (CHD).

Methods: LDL particle size determined by gradient gel electrophoresis and sd-LDL-C concentrations quantified by heparin-magnesium precipitation were compared between 482 stable CHD patients and 389 non-diabetic subjects without CHD who were not receiving any lipid-lowering drugs.

Results: Both male and female CHD patients had significantly smaller LDL particles and lower large-LDL-C concentrations (estimated by subtracting the sd-LDL-C concentration from the LDL-C concentration), and significantly higher sd-LDL-C concentrations than the control subjects. LDL-C concentrations were modestly higher and sd-LDL-C concentrations were significantly higher in 258 patients with angiographically documented severe CHD than in the patients with mild CHD irrespective of treatment by LDL-lowering drugs and history of myocardial infarction and/or coronary revascularization. Large-LDL-C concentrations, in contrast, were similar between the two groups. Multivariate logistic regression analysis revealed that sd-LDL-C levels were significantly associated with severe CHD independently of LDL-C.

Conclusion: sd-LDL-C levels are more powerful than LDL-C levels for the determination of severe stable CHD.

Citing Articles

Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes.

Hirano T J Diabetes Investig. 2025; 16(3):370-383.

PMID: 39778086 PMC: 11871407. DOI: 10.1111/jdi.14398.


Small dense low density lipoprotein predominance in patients with type 2 diabetes mellitus using Mendelian randomization.

Zhang F, Zhang Y, Zhang J, Wang X, Li Y, Wang W PLoS One. 2024; 19(2):e0298070.

PMID: 38330008 PMC: 10852223. DOI: 10.1371/journal.pone.0298070.


Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis.

Rikhi R, Schaich C, Hafzalla G, Patel N, Tannenbaum J, German C Eur J Prev Cardiol. 2024; 31(8):1048-1054.

PMID: 38323698 PMC: 11144463. DOI: 10.1093/eurjpc/zwae049.


Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.

Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S J Atheroscler Thromb. 2023; 31(6):641-853.

PMID: 38123343 PMC: 11150976. DOI: 10.5551/jat.GL2022.


Associations of perfluoroalkyl substances (PFAS) with lipid and lipoprotein profiles.

Haug M, Dunder L, Lind P, Lind L, Salihovic S J Expo Sci Environ Epidemiol. 2023; 33(5):757-765.

PMID: 37019983 PMC: 10541331. DOI: 10.1038/s41370-023-00545-x.